These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29740934)

  • 21. Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
    Zhang X; Yang S; Zhang P; Fu N
    Coron Artery Dis; 2020 May; 31(3):284-288. PubMed ID: 31658134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial.
    Yusuf J; Prakash G; Safal S; Mehta V; Mukhopadhyay S
    Coron Artery Dis; 2024 May; 35(3):186-192. PubMed ID: 38411168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.
    Yi B; Mo S; Jiang Y; Yi D; Luo J; Chen X; Rong J
    J Interv Cardiol; 2020; 2020():4527816. PubMed ID: 32982608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
    Duan N; Zhao J; Li Z; Dong P; Wang S; Zhao Y; Wang L; Wang H
    Med Sci Monit; 2015 Jan; 21():292-7. PubMed ID: 25613017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Value of Hepatorenal Status in Contrast-Induced Nephropathy Among Patients Receiving Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis.
    Zhang E; Lu Y; Chen G; Huang L; Zhang J; Wang C; Qin Q
    Angiology; 2019 Aug; 70(7):633-641. PubMed ID: 30525915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
    Zagler A; Azadpour M; Mercado C; Hennekens CH
    Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.
    Liu X; Hang Y; Shen L; Yang J; Zhou L; Sha W; Lu G
    Clin Nephrol; 2018 Nov; 90(5):313-324. PubMed ID: 30106366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of anti-oxidant supplementations on contrast-induced nephropathy after coronary angiography: an updated and comprehensive meta-analysis and systematic review.
    Ali-Hasan-Al-Saegh S; Mirhosseini SJ; Ghodratipour Z; Sarafan-Chaharsoughi Z; Dehghan AM; Rahimizadeh E; Shahidzadeh A; Lotfaliani MR; Sedaghat-Hamedani F; Kayvanpour E; Sabashnikov A; Popov AF
    Kardiol Pol; 2016; 74(7):610-26. PubMed ID: 26779856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
    Altunoren O; Balli M; Eren N; Tasolar H; Arpaci A; Caglayan CE; Yavuz YC; Gungor O
    Kidney Blood Press Res; 2015; 40(5):533-41. PubMed ID: 26496491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures - Systematic review and meta-analysis of randomized controlled trials.
    Pranata R; Yonas E; Vania R; Lukito AA
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):51-59. PubMed ID: 33390574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
    Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization.
    Zeng Z; Fu X; Zhang X; Fu N
    Int Urol Nephrol; 2019 Nov; 51(11):1999-2004. PubMed ID: 31385178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.